The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger.

The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger.
Oncoinvent ASA

Recent News

Oncoinvent presents 3Q company update in live webcast

Read more

Oncoinvent ASA: Grant of share options to new Chief Medical Officer

Read more

Oncoinvent appoints Dr Zuzana Jiráková Trnková as Chief Medical Officer to lead Phase 3 preparations for Radspherin[®]

Read more

Invitation to business update - Wednesday 28 October 2026

Read more

Oncoinvent ASA - Cancellation of subsequent repair offering

Read more

Oncoinvent ASA – Disclosure of large shareholding

Read more

Oncoinvent ASA – Mandatory notification of trade – Return of lent shares following Private Placement

Read more

Oncoinvent ASA – New share capital registered

Read more

Oncoinvent to present three abstracts at EANM and ESMO 2026

Read more
All news